Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ironwood Pharmaceuticals (IRWD) Long-Term Debt Issuances (2017 - 2023)

Ironwood Pharmaceuticals' Long-Term Debt Issuances history spans 4 years, with the latest figure at $400.0 million for Q2 2023.

  • For Q2 2023, Long-Term Debt Issuances changed N/A year-over-year to $400.0 million; the TTM value through Dec 2024 reached $400.0 million, changed 0.0%, while the annual FY2024 figure was $150.0 million, 62.5% down from the prior year.
  • Long-Term Debt Issuances for Q2 2023 was $400.0 million at Ironwood Pharmaceuticals, up from $146.2 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $400.0 million in Q2 2023 and bottomed at $400.0 million in Q2 2023.